Company Overview:

Universal Ibogaine Inc. (TSXV: IBO) is a life sciences company, with a mission to transform addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorder, and ultimately to utilize that treatment protocol globally through planned future licensing agreements.

This Report covers the Price Action, Technical Indicators Analysis along with the Support Levels, Resistance Levels, and Recommendations on this stock.

Fundamental Highlights:

Strategic Asset Sale to Refocus on High-Value Research: The planned Kelburn asset sale strengthens liquidity, enables debt repayment, and supports regulatory filings, allowing the Company to streamline operations and concentrate on advancing its ibogaine clinical program with Health Canada.

Key Investment Risks: Execution Risk, Permitting & Regulatory Risk, Inflation, low volume, thin liquidity, etc

IBO’s Technical Observation:

Universal Ibogaine’s chart shows prolonged consolidation at key support with declining downside momentum. RSI is stabilizing near neutral and beginning to trend higher, suggesting selling pressure is waning. A flattening moving average indicates base-building conditions, setting the stage for a potential technical rebound on improved volume.

IBO’s Daily Price Chart

As per the above-mentioned price action and technical indicators analysis, a ‘Speculative Buy’ rating has been given Universal Ibogaine Inc. (TSXV: IBO) at the closing market price of CAD 0.005, as of 2^nd February 2026. Individuals can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario. 

Markets are trading in a highly volatile zone currently due to certain Macro & Micro-economic data and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels as on February 2, 2026. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Dividend Yield may vary as per the stock price movement. 

Note 5: Kalkine reports are prepared based on the stock prices captured either from REFINITIV or Trading View. Typically, REFINITIV or Trading View may reflect stock prices with a delay which could be a lag of 25-30 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and the uptrend may take a pause due to profit booking or selling interest.

Stop-loss: In general, it is a level to protect further losses in case of any unfavourable movement in the stock prices.